Zhejiang Tailin Bioengineering Co

Zhejiang Tailin Bioengineering Co PEG

PEG Ratio (Price/Earnings-to-Growth) of Zhejiang Tailin Bioengineering Co (300813.SZ) as of Oct 29, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Zhejiang Tailin Bioengineering Co is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of Zhejiang Tailin Bioengineering Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Tailin Bioengineering Co Stock analysis

What does Zhejiang Tailin Bioengineering Co do? Zhejiang Tailin Bioengineering Co., Ltd. generates revenue through the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products and organic substance analysis instruments. The company's main products consist of consumables, instruments, and equipment used in sterile drug production and quality control, targeting pharmaceutical manufacturers and laboratories. These products serve applications in medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection sectors. The firm distributes its products domestically and internationally, with a focus on the Chinese market and overseas markets. The company's revenue streams are derived from the sale of microbial detection and control technology system products, organic substance analysis instruments, and related consumables. Pharmaceutical manufacturers and laboratory facilities are the primary customers purchasing these products for quality assurance and production processes. The application segments include medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection, which are served through both domestic and international distribution channels. Zhejiang Tailin Bioengineering's business model centers on selling specialized pharmaceutical equipment to industries requiring sterile drug production and quality control. The firm's products are utilized across multiple sectors such as medical and health, food safety, disease prevention, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. Sales occur within the domestic market and overseas markets, with a strong emphasis on the Chinese market and international expansion. Zhejiang Tailin Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Tailin Bioengineering Co stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Zhejiang Tailin Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Zhejiang Tailin Bioengineering Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Zhejiang Tailin Bioengineering Co

All Key Metrics — Zhejiang Tailin Bioengineering Co